Our mission is to leverage scientific advancements in creating autologous biologic preparations, which enable physicians to optimize the practice of regenerative medicine.
Greyledge Technologies has created a technology platform that allows physicians the opportunity to integrate autologous PRP and BMCC biologic preparations into their practice. The process relies on the use of a controlled laboratory setting, coupled with a fully documented and validated sample analysis.
Greyledge Technologies was established to meet emerging physician demands to facilitate and utilize mechanisms of natural healing to augment and/or support repair of damaged tissue. Greyledge has developed novel, manual laboratory-based methods to process autologous whole blood and bone marrow tissues to produce injectable or implantable bioactive preparations. Each biologic preparation is carefully analyzed prior to return to the patient to ensure quality and to meet physician-specified compositions. Greyledge’s approach is flexible, allowing physicians to optimize their practice of medicine through maintaining the highest standards in preparing and analyzing autologous PRP and BMCC preparations.
Founder and Chief Executive Officer
Greyledge operations are currently being led by company Founder and CEO – David Karli. He is responsible for all aspects of company development, including the integration of a strong team of professionals to support Greyledge’s innovative approach to regenerative medicine.
Vice President Research and Regulatory Affairs
Dr. Sand recently joined the company to support on-going commercialization efforts, as well as initiate an active research program to advance the company’s technology platform.
Director of Operations
Mark establishes and leads many of our logistics, quality, and supporting processes as Greyledge Technologies expands its’ services throughout the United States.
Director of Training and Development
In his position as Director of Training & Development, his duties include all aspects of laboratory operations, training and providing other support to maintain Greyledge’s commitment to quality. Tim is a key element in the development and launch of new Laboratories.